This is the authors' abstract. We don't add key points for this paper.
Our scoping review has revealed knowledge gaps to inform future research in several ways: replication, terminology and inclusion. First, no standard approach to PPI in CPG development could be inferred from the research. Second, inconsistent terminology to describe patients and publics reduces clarity around which patients and publics have been involved in developing CPGs. Finally, the under-representation of research describing PPI in the development of screening, as opposed to treatment, CPGs warrants further attention.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bryant et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: